Prefrontal Dopamine D1 Receptors and Working Memory in Schizophrenia

Journal of Neuroscience

Volumn 22, Issue 9, 2002, Pages 3708-3719

  Abi Dargham, Anissa ^a,b   Mawlawi, Osama ^a   Lombardo, Ilise ^a   Gil, Roberto ^a   Martinez, Diana ^a   Huang, Yiyun ^a   Hwang, Dah Ren ^a   Keilp, John ^a   Kochan, Lisa ^a   Van Heertum, Ronald ^a   Gorman, Jack M ^a   Laruelle, Marc ^a  

^a New York State Psychiatric Institute ^*  (United States)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

D1 receptors; Dopamine; Positron emission tomography; Prefrontal cortex; Schizophrenia; Working memory

Indexed keywords

5 (7 BENZOFURANYL) 8 CHLORO 2,3,4,5 TETRAHYDRO 7 HYDROXY 3 METHYL 1H 3 BENZAZEPINE; DOPAMINE 1 RECEPTOR; DOPAMINE 1 RECEPTOR BLOCKING AGENT; BENZAZEPINE DERIVATIVE; BENZOFURAN DERIVATIVE; CARBON; DIAGNOSTIC AGENT; DOPAMINE RECEPTOR BLOCKING AGENT;

ADULT; ARTICLE; BINDING AFFINITY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BINDING; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; POSITRON EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; PRIORITY JOURNAL; SCHIZOPHRENIA; TASK PERFORMANCE; WORKING MEMORY; AGE; BINDING COMPETITION; CLINICAL TRIAL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; DRUG ANTAGONISM; MEMORY DISORDER; METABOLISM; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PREDICTION AND FORECASTING; PRINCIPAL COMPONENT ANALYSIS; SCINTISCANNING; SHORT TERM MEMORY;

ADULT; AGE FACTORS; BENZAZEPINES; BENZOFURANS; BINDING, COMPETITIVE; CARBON RADIOISOTOPES; DOPAMINE ANTAGONISTS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MEMORY DISORDERS; MEMORY, SHORT-TERM; NEUROPSYCHOLOGICAL TESTS; PREDICTIVE VALUE OF TESTS; PREFRONTAL CORTEX; PRINCIPAL COMPONENT ANALYSIS; RECEPTORS, DOPAMINE D1; SCHIZOPHRENIA; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0036581253     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.22-09-03708.2002     Document Type: Article

References (102)

1. Abi-Dargham A, Laruelle M, Seibyl J, Rattner Z, Baldwin RM, Zoghbi SS, Zea-Ponce Y, Bremner JD, Hyde TM, Charney DS, Hoffer PB, Innis RB (1994) SPECT measurement of benzodiazepine receptors in human brain with [123-I]iomazenil: kinetic and equilibrium paradigms. J Nucl Med 35:228-238.
2. Abi-Dargham A, Simpson N, Kegeles L, Parsey R, Hwang DR, Anjilvel S, Zea-Ponce Y, Lombardo I, Van Heertum R, Mann JJ, Foged C, Halldin C, Laruelle M (1999) PET studies of binding competition between endogenous dopamine and the D1 radiotracer [11C]NNC 756. Synapse 32:93-109.
3. Abi-Dargham A, Martinez D, Mawlawi O, Simpson N, Hwang DR, Slifstein M, Anjilvel S, Pidcock J, Guo NN, Lombardo I, Mann JJ, Van Heertum R, Foged C, Halldin C, Laruelle M (2000) Measurement of striatal and extrastriatal dopamine D1 receptor binding potential with [11C]NNC 112 in humans: validation and reproducibility. J Cereb Blood Flow Metab 20:225-243.
4. Akil M, Pierri JN, Whitehead RE, Edgar CL, Mohila C, Sampson AR, Lewis DA (1999) Lamina-specific alterations in the dopamine innervation of the prefrontal cortex in schizophrenic subjects. Am J Psychiatry 156:1580-1589.
5. Andersen PH, Gronvald FC, Hohlweg R, Hansen LB, Guddal E, Braestrup C, Nielsen EB (1992) NNC-112, NNC-687 and NNC-756, new selective and highly potent dopamine D1 receptor antagonists. Eur J Pharmacol 219:45-52.
6. Arnsten AF, Goldman-Rakic PS (1998) Noise stress impairs prefrontal cortical cognitive function in monkeys: evidence for a hyperdopaminergic mechanism. Arch Gen Psychiatry 55:362-368.
7. Arnsten AF, Cai JX, Murphy BL, Goldman-Rakic PS (1994) Dopamine D1 receptor mechanisms in the cognitive performance of young adult and aged monkeys. Psychopharmacology 116:143-151.
8. Barch DM, Braver TS, Nystrom LE, Forman SD, Noll DC, Cohen JD (1997) Dissociating working memory from task difficulty in human prefrontal cortex. Neuropsychologia 35:1373-1380.
9. Barch DM, Carter CS, Braver TS, Sabb FW, MacDonald III A, Noll DC, Cohen JD (2001) Selective deficits in prefrontal cortex function in medication-naive patients with schizophrenia. Arch Gen Psychiatry 58:280-288.
10. Braff DL, Heaton R, Kuck J, Cullum M, Moranville J, Grant I, Zisook S (1991) The generalized pattern of neuropsychological deficits in out-patients with chronic schizophrenia with heterogeneous Wisconsin Card Sorting Test results. Arch Gen Psychiatry 48:891-898.
11. Braver TS, Cohen JD, Nystrom LE, Jonides J, Smith EE, Noll DC (1997) A parametric study of prefrontal cortex involvement in human working memory. NeuroImage 5:49-62.
12. Brozoski TJ, Brown RM, Rosvold HE, Goldman PS (1979) Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey. Science 205:929-932.
13. Cai JX, Arnsten AFT (1997) Dose-dependent effects of the dopamine D1 receptor agonists A77636 or SKF81297 on spatial working memory in aged monkeys. J Pharmacol Exp Ther 283:183-189.
14. Callicott JH, Ramsey NF, Tallent K, Bertolino A, Knable MB, Coppola R, Goldberg T, vanGelderen P, Mattay VS, Frank JA, Moonen CTW, Weinberger DR (1998) Functional magnetic resonance imaging brain mapping in psychiatry: methodological issues illustrated in a study of working memory in schizophrenia. Neuropsychopharmacology 18:186-196.
15. Callicott JH, Mattay VS, Bertolino A, Finn K, Coppola R, Frank JA, Goldberg TE, Weinberger DR (1999) Physiological characteristics of capacity constraints in working memory as revealed by functional MRI. Cereb Cortex 9:20-26.
16. Callicott JH, Bertolino A, Mattay VS, Langheim FJ, Duyn J, Coppola R, Goldberg TE, Weinberger DR (2000) Physiological dysfunction of the dorsolateral prefrontal cortex in schizophrenia revisited. Cereb Cortex 10:1078-1092.
17. Carlson S, Martinkauppi S, Rama P, Salli E, Korvenoja A, Aronen HJ (1998) Distribution of cortical activation during visuospatial n-back tasks as revealed by functional magnetic resonance imaging. Cereb Cortex 8:743-752.
18. Carter CS, Perlstein W, Ganguli R, Brar J, Mintun M, Cohen JD (1998) Functional hypofrontality and working memory dysfunction in schizophrenia. Am J Psychiatry 155:1285-1287.
19. Castner SA, Williams GV, Goldman-Rakic PS (2000) Reversal of antipsychotic-induced working memory deficits by short-term dopamine D1 receptor stimulation. Science 287:2020-2022.
20. Chou YH, Karlsson P, Halldin C, Olsson H, Farde L (1999) A PET study of D1-like dopamine receptor ligand binding during altered endogenous dopamine levels in the primate brain. Psychopharmacology 146:220-227.
21. Cohen JD, Forman SD, Braver TS, Casey BJ, Servan-Schreiber D, Noll DC (1994) Activation of the prefrontal cortex in a nonspatial working memory task with functional MRI. Human Brain Mapp 1:293-304.
22. Conklin HM, Curtis CE, Katsanis J, Iacono WG (2000) Verbal working memory impairment in schizophrenia patients and their first-degree relatives: evidence from the digit span task. Am J Psychiatry 157:275-277.
23. Courtney SM, Ungerleider LG, Keil K, Haxby JV (1996) Object and spatial visual working memory activate separate neural systems in human cortex. Cereb Cortex 6:39-49.
24. D'Esposito M, Ballard D, Aguirre GK, Zarahn E (1998) Human prefrontal cortex is not specific for working memory: a functional MRI study. NeuroImage 8:274-282.
25. Daniel DG, Berman KF, Weinberger DR (1989) The effect of apomorphine on regional cerebral blood flow in schizophrenia. J Neuropsychiatry Clin Neurosci 1:377-384.
26. Daniel DG, Weinberger DR, Jones DW, Zigun JR, Coppola R, Handel S, Bigelow LB, Goldberg TE, Berman KF, Kleinman JE (1991) The effect of amphetamine on regional cerebral blood flow during cognitive activation in schizophrenia. J Neurosci 11:1907-1917.
27. Davis KL, Kahn RS, Ko G, Davidson M (1991) Dopamine in schizophrenia: a review and reconceptualization. Am J Psychiatry 148:1474-1486.
28. de Beaurepaire R, Labelle A, Naber D, Jones BD, Barnes TR (1995) An open trial of the D1 antagonist SCH 39166 in six cases of acute psychotic states. Psychopharmacology (Berl) 121:323-327.
29. Den Boer JA, van Megen HJ, Fleischhacker WW, Louwerens JW, Slaap BR, Westenberg HG, Burrows GD, Srivastava ON (1995) Differential effects of the D1-DA receptor antagonist SCH39166 on positive and negative symptoms of schizophrenia. Psychopharmacology (Berl) 121:317-322.
30. Dolan RJ, Fletcher P, Frith CD, Friston KJ, Frackowiak RS, Grasby PM (1995) Dopaminergic modulation of impaired cognitive activation in the anterior cingulate cortex in schizophrenia. Nature 378:180-182.
31. Dumartin B, Jaber M, Gonon F, Caron MG, Giros B, Bloch B (2000) Dopamine tone regulates D1 receptor trafficking and delivery in striatal neurons in dopamine transporter-deficient mice. Proc Natl Acad Sci USA 97:1879-1884.
32. Duvernoy H (1991) The human brain. Surface, three-dimensional sectional anatomy and MRI. New York: Springer-Verlag Wien.
33. Fleming K, Goldberg TE, Gold JM, Weinberger DR (1995) Verbal working memory dysfunction in schizophrenia: use of a Brown-Peterson paradigm. Psychiatry Res 56:155-161.
34. Gandelman MS, Baldwin RM, Zoghbi SS, Zea-Ponce Y, Innis RB (1994) Evaluation of ultrafiltration for the free fraction determination of single photon emission computerized tomography (SPECT) radiotracers: β-CIT, IBF and iomazenil. J Pharm Sci 83:1014-1019.
35. Gold JM, Carpenter C, Randolph C, Goldberg TE, Weinberger DR (1997) Auditory working memory and Wisconsin Card Sorting Test performance in schizophrenia. Arch Gen Psychiatry 54:159-165.
36. Goldman-Rakic PS (1994) Working memory dysfunction in schizophrenia. J Neuropsychiatry Clin Neurosci 6:348-357.
37. Goldman-Rakic PS, Muly III EC, Williams GV (2000) D(1) receptors in prefrontal cells and circuits. Brain Res Brain Res Rev 31:295-301.
38. Green MF (1996) What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry 153:321-330.
39. Guo N, Waterhouse RN, Hwang DR, Zea-Ponce Y, Huang Y, Simpson N, Castillon J, Abi-Dargham A, Laruelle M (2000) Effect of acute endogenous dopamine depletion on in vivo binding of dopamine D1 and D2 radiotracers. NeuroImage 11:S4.
40. Guo N, Hwang D, Abdellhadi S, Abi-Dargham A, Zarahn E, Laruelle M (2001) The effect of chronic DA depletion on D1 ligand binding in rodent brain. Soc Neurosci Abstr 27:238.10.
41. Hall H, Sedvall G, Magnusson O, Kopp J, Halldin C, Farde L (1994) Distribution of D1- and D2-dopamine receptors, and dopamine and its metabolites in the human brain. Neuropsychopharmacology 11:245-256.
42. Halldin C, Foged C, Chou YH, Karlsson P, Swahn CG, Sandell J, Sedvall G, Farde L (1998) Carbon-11-NNC 112: a radioligand for PET examination of striatal and neocortical D1-dopamine receptors. J Nucl Med 39:2061-2068.
43. Hess EJ, Bracha HS, Kleinman JE, Creese I (1987) Dopamine receptor subtype imbalance in schizophrenia. Life Sci 40:1487-1497.
44. Hollingshead AB (1975) Four factor index of social status. New Haven, CT: Working paper published by the author.
45. Honey GD, Bullmore ET, Soni W, Varatheesan M, Williams SC, Sharma T (1999) Differences in frontal cortical activation by a working memory task after substitution of risperidone for typical antipsychotic drugs in patients with schizophrenia. Proc Natl Acad Sci USA 96:13432-13437.
46. Hurd YL, Suzuki M, Sedvall GC (2001) D1 and D2 dopamine receptor mRNA expression in whole hemisphere sections of the human brain. J Chem Neuroanat 22:127-137.
47. Jansma JM, Ramsey NF, Coppola R, Kahn RS (2000) Specific versus nonspecific brain activity in a parametric N-back task. NeuroImage 12:688-697.
48. Javitt DC, Zukin SR (1991) Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 148:1301-1308.
49. Jentsch JD, Roth RH (1999) The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 20:201-225.
50. Joyce JN, Lexow N, Bird E, Winokur A (1988) Organization of dopamine D1 and D2 receptors in human striatum: receptor autoradiographic studies in Huntington's disease and schizophrenia. Synapse 2:546-557.
51. Kahn RS, Harvey PD, Davidson M, Keefe RS, Apter S, Neale JM, Mohs RC, Davis KL (1994) Neuropsychological correlates of central monoamine function in chronic schizophrenia: relationship between CSF metabolites and cognitive function. Schizophr Res 11:217-224.
52. Karle J, Clemmesen L, Hansen L, Andersen M, Andersen J, Fensbo C, Sloth-Nielsen M, Skrumsager BK, Lublin H, Gerlach J (1995) NNC 01-0687, a selective dopamine D1 receptor antagonist, in the treatment of schizophrenia. Psychopharmacology (Berl) 121:328-329.
53. Karlsson P, Smith L, Farde L, Harnryd C, Sedvall G, Wiesel FA (1995) Lack of apparent antipsychotic effect of the D1-dopamine receptor antagonist SCH39166 in acutely ill schizophrenic patients. Psychopharmacology (Berl) 121:309-316.
54. Kates WR, Abrams MT, Kaufmann WE, Breiter SN, Reiss AL (1997) Reliability and validity of MRI measurement of the amygdala and hippocampus in children with fragile X syndrome. Psychiatry Res 75:31-48.
55. Kay SR, Fiszbein A, Opler LA (1987) The Positive and Negative Syndrome scale (PANSS) for schizophrenia. Schizophrenia Bull 13:261-276.
56. Keefe RS, Lees-Roitman SE, Dupre RL (1997) Performance of patients with schizophrenia on a pen and paper visuospatial working memory task with short delay. Schizophr Res 26:9-14.
57. Killiany RJ, Moss MB, Nicholson T, Jolez F, Sandor T (1997) An interactive procedure for extracting features of the brain from magnetic resonance images: the lobes. Human Brain Mapp 5:355:363.
58. Knable MB, Hyde TM, Murray AM, Herman MM, Kleinman JE (1996) A postmortem study of frontal cortical dopamine D1 receptors in schizophrenics, psychiatric controls, and normal controls. Biol Psychiatry 40:1191-1199.
59. Laruelle M (2000) Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review. J Cereb Blood Flow Metab 20:423-451.
60. Laruelle M, Casanova M, Weinberger D, Kleinman J (1990) Postmortem study of the dopaminergic D1 receptors in the dorsolateral prefrontal cortex of schizophrenics and controls. Schizophr Res 3:30-31.
61. Laruelle M, Sidhu A, Casanova MF, Weinberger DR, Kleinman JE (1991) Characterization of [125I]SCH23982 binding in human brain: comparison with [3H]SCH23390. Neurosci Lett 31:273-276.
62. 2 receptors in healthy subjects. J Nucl Med 35:743-754.
63. Laruelle M, Baldwin RM, Rattner Z, Al-Tikriti MS, Zea-Ponce Y, Zoghbi SS, Charney DS, Price JC, Frost JJ, Hoffer PB, Innis RB (1994b) SPECT quantification of [123I]iomazenil binding to benzodiazepine receptors in nonhuman primates. I. Kinetic modeling of single bolus experiments. J Cereb Blood Flow Metab 14:439-452.
64. Levenberg K (1944) A method for the solution of certain problems in least squares. Quart Appl Math 2:164-168.
65. Levitt P, Rakic P, Goldman-Rakic P (1984) Region-specific distribution of catecholamine afferents in primate cerebral cortex: a fluorescence histochemical analysis. J Comp Neurol 227:23-36.
66. Lewis DA, Campbell MJ, Foote SL, Goldstein M, Morrison JH (1987) The distribution of tyrosine hydroxylase-immunoreactive fibers in primate neocortex is widespread but regionally specific. J Neurosci 7:279-290.
67. Lidow MS, Goldman-Rakic PS (1994) A common action of clozapine, haloperidol, and remoxipride on D1- and D2-dopaminergic receptors in the primate cerebral cortex. Proc Natl Acad Sci USA 91:4353-4356.
68. Lidow MS, Goldman-Rakic PS, Gallager DW, Rakic P (1991) Distribution of dopaminergic receptors in the primate cerebral cortex: quantitative autoradiographic analysis using [3H]raclopride, [3H]spiperone and [3H]SCH23390. Neuroscience 40:657-671.
69. Lidow MS, Elsworth JD, Goldman-Rakic PS (1997) Down-regulation of the D1 and D5 dopamine receptors in the primate prefrontal cortex by chronic treatment with antipsychotic drugs. J Pharmacol Exp Ther 281:597-603.
70. Manoach DS, Press DZ, Thangaraj V, Searl MM, Goff DC, Halpern E, Saper CB, Warach S (1999) Schizophrenic subjects activate dorsolateral prefrontal cortex during a working memory task, as measured by fMRI. Biol Psychiatry 45:1128-1137.
71. Manoach DS, Gollub RL, Benson ES, Searl MM, Goff DC, Halpern E, Saper CB, Rauch SL (2000) Schizophrenic subjects show aberrant fMRI activation of dorsolateral prefrontal cortex and basal ganglia during working memory performance. Biol Psychiatry 48:99-109.
72. Mawlawi OM, Weiss R, Shinn A, Pidcock J, Slifstien M, Laruelle M (1999) Performance characteristics of a head immobilization device for PET imaging. J Nucl Med 40:281.P.
73. Mawlawi O, Martinez D, Slifstein M, Broft A, Chatterjee R, Hwang DR, Huang Y, Simpson N, Ngo K, Van Heertum R, Laruelle M (2001) Imaging human mesolimbic dopamine transmission with positron emission tomography: I. Accuracy and precision of D2 receptor parameter measurements in ventral striatum. J Cereb Blood Flow Metab 21:1034-1057.
74. McCarthy G, Blamire AM, Puce A, Nobre AC, Bloch G, Hyder F, Goldman-Rakic P, Shulman RG (1994) Functional magnetic resonance imaging of human prefrontal cortex activation during a spatial working memory task. Proc Natl Acad Sci USA 91:8690-8694.
75. Meador-Woodruff JH, Haroutunian V, Powchik P, Davidson M, Davis KL, Watson SJ (1997) Dopamine receptor transcript expression in striatum and prefrontal and occipital cortex. Focal abnormalities in orbitofrontal cortex in schizophrenia. Arch Gen Psychiatry 54:1089-1095.
76. Mintun MA, Raichle ME, Kilbourn MR, Wooten GF, Welch MJ (1984) A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography. Ann Neurol 15:217-227.
77. Morice R, Delahunty A (1996) Frontal/executive impairments in schizophrenia. Schizophr Bull 22:125-137.
78. Murphy BL, Arnsten AF, Goldman-Rakic PS, Roth RH (1996a) Increased dopamine turnover in the prefrontal cortex impairs spatial working memory performance in rats and monkeys. Proc Natl Acad Sci USA 93:1325-1329.
79. Murphy BL, Arnsten AF, Jentsch JD, Roth RH (1996b) Dopamine and spatial working memory in rats and monkeys: pharmacological reversal of stress-induced impairment. J Neurosci 16:7768-7775.
80. Oades RD, Halliday GM (1987) Ventral tegmental (A10) system: neurobiology. 1. Anatomy and connectivity. Brain Res 434:117-165.
81. Okubo Y, Suhara T, Suzuki K, Kobayashi K, Inoue O, Terasaki O, Someya Y, Sassa T, Sudo Y, Matsushima E, Iyo M, Tateno Y, Toru M (1997) Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET. Nature 385:634-636.
82. Pani L, Gessa GL, Carboni S, Portas CM, Rossetti ZL (1990) Brain dialysis and dopamine: does the extracellular concentration of dopamine reflect synaptic release? Eur J Pharmacol 180:85-90.
83. Park S (1997) Association of an oculomotor delayed response task and the Wisconsin Card Sort Test in schizophrenic patients. Int J Psychophysiol 27:147-151.
84. Park S, Holzman PS (1992) Schizophrenics show spatial working memory deficits. Arch Gen Psychiatry 49:975-982.
85. Perlstein WM, Carter CS, Noll DC, Cohen JD (2001) Relation of prefrontal cortex dysfunction to working memory and symptoms in schizophrenia. Am J Psychiatry 158:1105-1113.
86. Pimoule C, Schoemaker H, Reynolds GP, Langer SZ (1985) [3H]SCH 23390 labeled D1 dopamine receptors are unchanged in schizophrenia and Parkinson's disease. Eur J Pharmacol 114:235-237.
87. Rajkowska G, Goldman-Rakic PS (1995) Cytoarchitectonic definition of prefrontal areas in the normal human cortex: II. Variability in locations of areas 9 and 46 and relationship to the Talairach coordinate system. Cereb Cortex 5:323-337.
88. Rama P, Martinkauppi S, Linnankoski I, Koivisto J, Aronen HJ, Carlson S (2001) Working memory of identification of emotional vocal expressions: an fMRI study. NeuroImage 13:1090-1101.
89. Reynolds GP, Czudek C (1988) Status of the dopaminergic system in post-mortem brain in schizophrenia. Psychopharmacol Bull 24:345-347.
90. Sawaguchi T, Goldman-Rakic PS (1991) D1 dopamine receptors in prefrontal cortex: involvement in working memory. Science 251:947-950.
91. Sawaguchi T, Goldman-Rakic PS (1994) The role of D1-dopamine receptor in working memory: local injections of dopamine antagonists into the prefrontal cortex of rhesus monkeys performing an oculomotor delayed-response task. J Neurophysiol 71:515-528.
92. Savkin AJ, Shtasel DL, Gur RE, Kester DB, Mozley LH, Stafiniak P, Gur RC (1994) Neuropsychological deficits in neuroleptic naive patients with first- episode schizophrenia. Arch Gen Psychiatry 51:124-131.
93. Seeman P, Bzowej NH, Guan HC, Bergeron C, Reynolds GP, Bird ED, Riederer P, Jellinger K, Tourtelotte WW (1987) Human brain D1 and D2 dopamine receptors in schizophrenia, Alzheimer's, Parkinson's, and Huntington's diseases. Neuropsychopharmacology 1:5-15.
94. Spitzer R, Williams J, Gibbon M, First M (1992) The Structured Clinical interview for DSM-III-R: 1. History, rationale and description. Arch Gen Psychiatry 49:624-629.
95. Stevens AA, Goldman-Rakic PS, Gore JC, Fulbright RK, Wexler BE (1998) Cortical dysfunction in schizophrenia during auditory word and tone working memory demonstrated by functional magnetic resonance imaging. Arch Gen Psychiatry 55:1097-1103.
96. Talairach J, Tournoux P (1988) Co-planar stereotactic atlas of the human brain. Three-dimensional proportional system: an approach of cerebral imaging. New York: Theime.
97. Watanabe M, Kodama T, Hikosaka K (1997) Increase of extracellular dopamine in primate prefrontal cortex during a working memory task. J Neurophysiol 78:2795-2798.
98. Weinberger DR (1987) Implications of the normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 44:660-669.
99. Weinberger DR, Berman KF, Illowsky BP (1988) Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. III. A new cohort and evidence for a monoaminergic mechanism. Arch Gen Psychiatry 45:609-615.
100. Woods RP, Cherry SR, Mazziotta JC (1992) Rapid automated algorithm for aligning and reslicing PET images. J Comp Assist Tomogr 16:620-633.
101. Woods RP, Mazziotta JC, Cherry SR (1993) MRI-PET registration with automated algorithm. J Comput Assist Tomogr 17:536-546.
102. Zahrt J, Taylor JR, Mathew RG, Arnsten AF (1997) Supranormal stimulation of D1 dopamine receptors in the rodent prefrontal cortex impairs spatial working memory performance. J Neurosci 17:8528-8535.